Last $0.81 USD
Change Today -0.04 / -4.71%
Volume 14.0K
CDXI On Other Exchanges
Symbol
Exchange
OTC BB
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

cardax inc (CDXI) Snapshot

Open
$0.81
Previous Close
$0.85
Day High
$0.83
Day Low
$0.76
52 Week High
02/18/14 - $2.00
52 Week Low
02/5/14 - $0.11
Market Cap
50.9M
Average Volume 10 Days
12.6K
EPS TTM
$-0.0009
Shares Outstanding
62.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CARDAX INC (CDXI)

Related News

No related news articles were found.

cardax inc (CDXI) Related Businessweek News

No Related Businessweek News Found

cardax inc (CDXI) Details

Cardax, Inc., a development stage life sciences company, develops nutraceutical and pharmaceutical products that provide the anti-inflammatory benefits of steroids or non-steroidal anti-inflammatory drugs. It primarily focuses on developing astaxanthin technologies for unmet medical needs. Astaxanthin is a naturally occurring marine compound that has anti-oxidant and anti-inflammatory activity. The company is also preparing proprietary nature-identical products and related derivatives by total synthesis to provide therapies for diseases where inflammation and oxidative stress are implicated, including osteoarthritis, rheumatoid arthritis, dyslipidemia, metabolic disease, diabetes, cardiovascular disease, hepatitis, cognitive decline, macular degeneration, and prostate disease. Cardax, Inc. is based in Honolulu, Hawaii.

9 Employees
Last Reported Date: 03/31/14

cardax inc (CDXI) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: $455.9K
Executive Chairman, Chairman of Nominating & ...
Total Annual Compensation: $217.9K
Vice President of Operations, Assistant Treas...
Total Annual Compensation: $143.6K
Vice President of Research
Total Annual Compensation: $154.6K
Chief Science Officer and Member of Scientifi...
Total Annual Compensation: $121.5K
Compensation as of Fiscal Year 2013.

cardax inc (CDXI) Key Developments

Cardax, Inc. Announces Board Appointments

Cardax, Inc. announced the appointment of George W. Bickerstaff, former CFO of Novartis Pharma AG, Tamar D. Howson, former senior business development executive at Bristol-Myers Squibb and SmithKline Beecham, and Terence A. Kelly, Ph.D., former senior Boehringer Ingelheim anti-inflammatory R&D executive and current CEO of CoMentis, as independent members of its board of directors. They will join current Executive Chairman Nicholas Mitsakos, independent director Frank Herringer, and Cardax CEO David G. Watumull on the Cardax board.

Koffee Korner Inc. will Change its Name to Cadax InC

Effective February 21, 2014, Koffee Korner Inc. will change its name to Cadax InC.

Cardax, Inc. announced delayed 10-Q filing

On 02/13/2014, Cardax, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CDXI:US $0.81 USD -0.04

CDXI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CDXI.
View Industry Companies
 

Industry Analysis

CDXI

Industry Average

Valuation CDXI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDAX INC, please visit www.cardaxpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.